[Effect of indirect endolymphatic antibiotic therapy on clinical and immunological indicators in patients with erysipelas of the lower extremities] NLM AIDSLINE Important note: Information in this article was accurate in 1993. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


[Effect of indirect endolymphatic antibiotic therapy on clinical and immunological indicators in patients with erysipelas of the lower extremities]

Antibiot Khimioter. 1992 Jun;37(6):24-6. Unique Identifier : AIDSLINE MED/93037907
Levina LD; Ambalov IuM; Poliak AI; Aitkuluev NS; Kovalenko AP; Usatkin AV

Abstract: Two groups of patients with erysipelas of the lower extremities underwent indirect endolymphatic therapy with bicillin-3 (58 patients) and routine penicillin therapy (79 patients). Comparative clinicoimmunological examinations in the two groups revealed that lymphotropic administration of the antibiotic had a more favourable effect on the disease process, as evidenced by more rapid reverse time courses of erysipelas clinical signs, less frequent incidence of early relapses and normalization of the majority of immunological parameters by the end of the treatment. For estimation of the anti-recurrence efficacy of the antibiotic therapy in the patients with erysipelas, it was recommended to use a specific scale based on the principles of the Wald successive alternative analysis.
Keywords: Adult Aged Antibiotics, Combined/ADMINISTRATION & DOSAGE Antigen-Antibody Complex/*ANALYSIS Antigens, CD3/*ANALYSIS CD4-CD8 Ratio/*DRUG EFFECTS English Abstract Erysipelas/*DRUG THERAPY/IMMUNOLOGY Human Injections, Intralymphatic Leg Dermatoses/*DRUG THERAPY/IMMUNOLOGY Middle Age Penicillin G/*ADMINISTRATION & DOSAGE Penicillin G, Benzathine/*ADMINISTRATION & DOSAGE Penicillin G, Procaine/*ADMINISTRATION & DOSAGE CLINICAL TRIAL CONTROLLED CLINICAL TRIAL JOURNAL ARTICLEKWDadultagedantibiotics,combined/administration&dosageantigen-antibodycomplex/KWDanalysisantigens,cd3/KWDanalysiscd4-cd8ratio/KWDdrugeffectsenglishabstracterysipelas/KWDdrugtherapy/immunologyhumaninjections,intralymphaticlegdermatoses/KWDdrugtherapy/immunologymiddleagepenicilling/KWDadministration&dosagepenicilling,benzathine/KWDadministration&dosagepenicilling,procaine/KWDadministration&dosageclinicaltrialcontrolledclinicaltrialjournalarticle
930130
M9310283

Copyright © 1993 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1993. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1993. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .